Henry Schein | HSIC - Ebit

Stock Price
72.72
Daily Change
0.11 0.15%
Monthly
-5.82%
Yearly
0.93%
Q2 Forecast
71.26

Henry Schein reported $194M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Agilent USD 353M 90M Dec/2025
Align Technology USD 178.05M 46.66M Mar/2026
Bruker USD 10.2M 66.1M Mar/2026
Cardinal Health USD 861M 98M Mar/2026
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Cigna USD 2.76B 583M Mar/2026
Concord Medical Services Hldg CNY -144.65M 69.38M Jun/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
CVS Health USD 4.68B 2.57B Mar/2026
Danaher USD 1.34B 158M Mar/2026
Dentsply International USD 32M 506M Mar/2026
Encompass Health USD 319.1M 35.7M Mar/2026
Henry Schein USD 194M 8M Mar/2026
Idexx Laboratories USD 362.59M 46.98M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Laboratory Of America USD 410.1M 28.1M Mar/2026
McKesson USD 1.84B 181M Mar/2026
Mettler Toledo International USD 233.93M 118M Mar/2026
Owens Minor USD 814K 28.08M Dec/2025
Quest Diagnostics USD 399M 13M Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Tenet Healthcare USD 1.38B 509M Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Universal Health Services USD 502.86M 14.37M Mar/2026
Veradigm USD -45.47M 70.47M Dec/2022
Waters USD 148M 122.52M Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026
Zoetis USD 842M 7M Mar/2026